HNRNPCP9

Across TCGA pan-cancer cohorts, HNRNPCP9 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated HNRNPCP9 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher HNRNPCP9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HNRNPCP9 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

KIRC, THYM, and LUAD are the cancer types where HNRNPCP9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	All	0.518	0.674	.003	84	view →
THYM	DFS	Tertile	II,III,IV	0.398	0.926	<.001	51	view →
LUAD	DFS	Tertile	III,IV	0.323	0.672	<.001	45	view →
ACC	DFS	Tertile	II,III,IV	0.084	0.467	.001	39	view →
HNSC	DFS	Quartile	II,III,IV	0.840	0.595	.008	39	view →
LIHC	OS	Tertile	All	0.324	0.542	.001	36	view →
LUSC	OS	Quartile	III,IV	0.494	0.736	.004	26	view →
SKCM	DFS	Tertile	IV	0.046	0.518	.003	24	view →
BLCA	DFS	Tertile	III,IV	0.189	0.523	<.001	24	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
COAD	DFS	Tertile	III,IV	0.300	0.584	.005	18	view →
THCA	DFS	Tertile	II,III,IV	0.469	0.809	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

HNRNPCP9–KIRC (OS)

Open the KIRC breakdown →